Article
Preexisting Enhancing Antibodies in Vaccinated Participants Accelerate Dengue Virus 1 Infection Following Live Virus Human Challenge
2023-09-15
Abstract excerpt
<title>Abstract</title> <p>Dengue Human Infection Models (DHIM) are needed to down-select dengue vaccine candidates and establish tetravalent efficacy before advanced clinical field trials. As part of a randomized heterologous prime-boost vaccine strategy, participants received a tetravalent dengue (TDEN) Purified Inactivated Vaccine (PIV) prime followed by a TDEN Live Attenuated Vaccine (LAV) boost at 28, 90 or...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 608517d1-df6a-594b-8f90-cc67192e2a9a
- DOI
- 10.21203/rs.3.rs-3237925/v1
